Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27505731 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL8492695 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL679248 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL2914509 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL1498742 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL23521368 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL8341797 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL11513011 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL1498841 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 | |
| SCHEMBL365322 | 1.00 | FAAH (0.62) | FAAHMEN1MAPK1KMT2AASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268255-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2025-08-28 | — | — | US | claimed |
| US-12324433-B2 | Antimicrobial enhancement of cationic active skin antiseptics | ECOLAB USA INC. (US) | 2025-06-10 | — | — | US | claimed |
| US-12285825-B2 | Non-aqueous solder flux composition | STEPAN COMPANY (US) | 2025-04-29 | — | — | US | claimed |
| EP-4507652-A1 | PERSONAL CLEANSING COMPOSITION FREE OF ALKYL SULFATE OR ALKYL ETHER SULFATE TYPE OF SURFACTANTS | The Procter & Gamble Company (US) | 2025-02-19 | — | — | EP | claimed |
| US-12070516-B2 | Hair styling compositions | L'OREAL (FR) | 2024-08-27 | — | — | US | claimed |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | L'OREAL (FR) | 2024-06-20 | — | — | US | claimed |
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | ECOLAB USA INC. | 2024-05-02 | — | — | US | claimed |
| WO-2024090925-A1 | HAIR DYE COMPOSITION CONTAINING POTASSIUM ALUM AND POLYURETHANE-10 | 코스맥스 주식회사 | 2024-05-02 | — | — | WO | claimed |
| US-11889832-B2 | Antimicrobial enhancement of cationic active skin antiseptics | ECOLAB USA INC. (US) | 2024-02-06 | — | — | US | claimed |
| CN-114096376-B | Nonaqueous flux composition | 斯泰潘公司 | 2023-10-31 | — | — | CN | claimed |
| US-20220072002-A1 | TREATMENT USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND | CHIA TAI TIANQING PHARMACEUTICALGROUP CO., LTD. (CN) | 2022-03-10 | — | — | US | claimed |
| CN-114096376-A | Non-aqueous flux composition | 斯泰潘公司 | 2022-02-25 | — | — | CN | claimed |
| EP-2644650-B1 | RUBBER COMPOSITION AND TIRE USING THE SAME | BRIDGESTONE CORP (JP) | 2017-10-25 | — | — | EP | claimed |
| CN-102604731-A | Water-borne aluminum foil working fluid | FOSHAN SHUNDE FUYANSHENG LUBRICANT CO LTD | 2012-07-25 | — | — | CN | claimed |
| EP-1175197-B1 | ALKANOLAMIDE SURFACTANT EMULSIONS AND PROCESS THEREFOR | MCINTYRE GROUP LTD (US) | 2004-12-15 | — | — | EP | claimed |
| EP-0886551-B1 | STABILITY CONTROL AGENT COMPOSITION FOR POLYOLEFIN FOAM | KNAUS DENNIS A (US) | 2004-08-04 | — | — | EP | claimed |
| EP-1335756-A2 | ABSORPTION AGENTS WITH A HIGH SWELLING CAPACITY, WITH A REDUCED TENDENCY TO CAKE | STOCKHAUSEN GmbH & CO. KG (DE) | 2003-08-20 | — | — | EP | claimed |
| WO-2002034384-A2 | ABSORPTION AGENTS WITH A HIGH SWELLING CAPACITY, WITH A REDUCED TENDENCY TO CAKE | STOCKHAUSEN GMBH & CO. KG (DE) | 2002-05-02 | — | — | WO | claimed |
| US-6207614-B1 | MIXED CRYSTALS OF AT LEAST ONE ORGANIC SILVER SALT AND AT LEAST ONE ORGANIC FATTY ACID DERIVATIVE, AN ORGANIC REDUCING AGENT FOR THE ORGANIC SILVER SALT IN THERMAL WORKING RELATIONSHIP THEREWITH AND A BINDER | AGFA-GEVAERT (BE) | 2001-03-27 | — | — | US | claimed |
| US-4263321-A | N-HYDROXYPROPYLLAURAMIDE TO KILL ECTOPARISITES | BLOCK DRUG COMPANY INC. (US) | 1981-04-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250268255-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | FAAH 736/4885MEN1 4374/4885MAPK1 3545/4885 |
| US-20220072002-A1 | TREATMENT USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND | THPO, MPL, TPMT | FAAH 3746/4885MEN1 503/4885MAPK1 3808/4885 |
| US-20240197597-A1 | HAIR STYLING COMPOSITIONS | PIK3C3, POLR1C, ALKBH3 | FAAH 67/4885MEN1 4031/4885MAPK1 2513/4885 |
| US-12324433-B2 | Antimicrobial enhancement of cationic active skin antiseptics | CUTA, ARG1, LPO | FAAH 736/4885MEN1 4374/4885MAPK1 3545/4885 |
| US-12070516-B2 | Hair styling compositions | PIK3C3, POLR1C, ALKBH3 | FAAH 67/4885MEN1 4031/4885MAPK1 2513/4885 |
| US-11889832-B2 | Antimicrobial enhancement of cationic active skin antiseptics | CUTA, ARG1, LPO | FAAH 736/4885MEN1 4374/4885MAPK1 3545/4885 |
| US-20240138407-A1 | ANTIMICROBIAL ENHANCEMENT OF CATIONIC ACTIVE SKIN ANTISEPTICS | CUTA, ARG1, LPO | FAAH 736/4885MEN1 4374/4885MAPK1 3545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.